Actively Recruiting
Betamethasone (Betapred®) as Premedication for Reducing Postoperative Vomiting and Pain After Tonsillectomy
Led by Umeå University · Updated on 2024-05-14
100
Participants Needed
1
Research Sites
326 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Betamethasone is currently given routinely in conjunction with tonsillectomy surgery at the majority of Ear, Nose \& Throat clinics in Sweden. The scientific evidence regarding the effects of betamethasone in adults is limited when it comes to postoperative nausea (PONV), pain and postoperative bleeding.
CONDITIONS
Official Title
Betamethasone (Betapred®) as Premedication for Reducing Postoperative Vomiting and Pain After Tonsillectomy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Signed informed consent
- Age over 12 years
- Planned for elective bilateral tonsillectomy
You will not qualify if you...
- Insulin dependent diabetes mellitus
- NSAID or corticosteroid intolerance
- Pregnancy
- Gastric ulcer
- Immunodeficiency
- Treatment for chronic pain
- Psychiatric disorders
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Sunderby sjukhus
Luleå, Sweden, 971 80
Actively Recruiting
Research Team
K
Krister Tano, MD, PhD
CONTACT
M
My Rosén, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here